NOT-AI-20-034: Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome

RESCINDED replaced by NOT-AI-20-059

Funder: NIH: National Institute of Allergy and Infectious Diseases (NIAID)

RESCINDED VIA NOT-AI-20-058

Applications in response to this NOSI must be submitted using the following targeted funding opportunity:

  • PA-20-135; Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional), which is intended to provide funds for NIH grantees applying to expand the scope of their active grant.
  • The funding instrument, or activity code, will be the same as the parent award. All activity codes of currently funded NIAID grants are eligible.
  • Please note: NOT-AI-20-034 is specific for PA-20-135. NIH grantees seeking additional funds for research responsive to the SARS-CoV-2/COVID-19 outbreak that falls within the scope of an ongoing grant should instead apply for an administrative supplement under NIH PA-18-591, Administrative Supplements to Existing NIH Grants and Cooperative Agreements FOA (https://grants.nih.gov/grants/guide/pa-files/PA-18-591.html).

Learn More Contact OSR to Apply

Topics: Clinical Presentation of Infection, Co-Morbidities, Diagnostics, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Healthcare Implementation, Prevention, Research Model Development, Research Tool Development, Treatments, Vaccines, Virology, Virus Biology